Data / Form D filings / Spyryx Biosciences, Inc.
Spyryx Biosciences, Inc.: Form D filings
Spyryx Biosciences, Inc., a biotechnology company in Durham, NC, filed 4 Form D notices with the SEC between 2015 and 2018. The latest, on October 4, 2018, reports $5.9 million sold of a $6 million offering to 7 investors.
Find out what Spyryx Biosciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 801-10 CAPITOLA DRIVE, Durham, NC, 27713
- Phone
- (919) 899-9399
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1633540
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 4, 2018 | New notice | $6,000,000 | $5,929,941 | $70,059 | 7 | Oct 1, 2018 | sec.gov |
| Jul 12, 2017 | New notice | $5,000,000 | $5,000,000 | $0 | 13 | Jun 27, 2017 | sec.gov |
| May 8, 2015 | New notice | $18,172,004 | $18,172,004 | $0 | 13 | Apr 24, 2015 | sec.gov |
| Feb 11, 2015 | New notice | $1,000,000 | $15,000 | $985,000 | 1 | Jan 30, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tim Shannon | Director | |
| Brian Daniels | Director | |
| Roger Jeffs | Director | |
| Timm Crowder | Executive Officer, Promoter | |
| Christy Shaffer | Director | |
| Robert Tarran | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Oct 1, 2018 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Spyryx Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.